Results 1 to 10 of about 95,752 (337)

Comparison of early versus late addition of granulocyte and monocyte adsorption for incomplete remission induction in ulcerative colitis [PDF]

JGH Open
Background and aim Ulcerative colitis (UC) is characterized by repeated relapse and remission. Because no fundamental therapeutic strategy has been established, the treatment goal is generally to maintain the remission phase for a long period after rapid
Keiichi Tominaga, Mimari Kanazawa, Shoko Watanabe, Takanao Tanaka, Shunsuke Kojimahara, Satoshi Masuyama, Keiichiro Abe, Akira Kanamori, Akira Yamamiya, Takeshi Sugaya, Kenichi Goda, Yuji Fujita, Shigemi Yoshihara, Yasuo Haruyama, Atsushi Irisawa   +14 more
doaj   +2 more sources

Probiotics for induction of remission in Crohn's disease [PDF]

Cochrane Database of Systematic Reviews, 2008
Crohn's disease has a high morbidity and there is no known cure. Current treatments have multiple side effects and an effective treatment with minimal side effects is desired. Probiotics have been proposed as such a treatment but their efficacy is undetermined.
Andrew D Butterworth, Adrian G. Thomas, Anthony K Akobeng   +2 more
openalex   +3 more sources

Remission induction in acute myeloid leukemia [PDF]

International Journal of Hematology, 2012
Inducing a complete remission (CR) in patients with acute myeloid leukemia is a prerequisite to long-term disease control with subsequent post-remission consolidation chemotherapy or allogeneic hematopoietic stem cell transplantation. The use of 7 days of infusional cytarabine and 3 days of daunorubicin or idarubicin (7 + 3) has become the standard of ...
Eytan M. Stein, Martin S. Tallman
openalex   +5 more sources

VAD chemotherapy as remission induction for multiple myeloma [PDF]

British Journal of Cancer, 1995
A total of 142 patients with multiple myeloma received VAD as remission induction therapy. Seventy-five were previously untreated and 67 had relapsed (31) or refractory disease (36). Vincristine (total dose 1.6 mg) was infused with doxorubicin 36 mg m-2 by continuous ambulatory pump over 4 days. In addition, oral dexamethasone 40 mg day-1 was given for
Heather Anderson, J.H. Scarffe, Malcolm Ranson, Rosemary Young, GS Wieringa, GR Morgenstern, Lesley Fitzsimmons, R. E. J. Ryder   +7 more
openalex   +3 more sources

Traditional corticosteroids for induction of remission in Crohn's disease [PDF]

Cochrane Database of Systematic Reviews, 2008
Historically, corticosteroids have been the most commonly used class of medication for induction of remission in Crohn's disease (CD). Corticosteroids down regulate production of inflammatory cytokines and interfere with NF-kappaB production, thereby blunting inflammatory response.The primary objective was to systematically review the efficacy and ...
Eric I. Benchimol, Cynthia H. Seow, A. Hillary Steinhart, Anne M. Griffiths   +3 more
openalex   +4 more sources

Certolizumab pegol for induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews, 2017
Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract, and immune response modulation is the main treatment strategy to induce remission in active CD. Certolizumab pegol (CZP) is a tumor necrosis factor-alfa (TNF-α) inhibitor which regulates impaired immune response.The primary objectives were to evaluate the efficacy and
Hajime Yamazaki, Ryuhei So, Katsuyoshi Matsuoka, Taku Kobayashi, Shinichiro Shinzaki, Minoru Matsuura, Shinji Okabayashi, Yuki Kataoka, Yasushi Tsujimoto, Toshi A. Furukawa, Norio Watanabe   +10 more
openalex   +6 more sources

Coherent enhancement of optical remission in diffusive media [PDF]

Proc. Natl. Acad. Sci. U.S.A. Vol. 119, e2207089119 (2022), 2022
From the earth's crust to the human brain, remitted waves are used for sensing and imaging in a diverse range of diffusive media. Separating the source and detector increases the penetration depth of remitted light, yet rapidly decreases the signal strength, leading to a poor signal-to-noise ratio.
arxiv   +1 more source

Serum ferritin is a good indicator for predicting the efficacy of adult HLH induction therapy

Annals of Medicine, 2022
Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome with a high mortality rate. There is no biomarker to predict the early therapeutic response.
Zhengjie Hua, Lingbo He, Ruoxi Zhang, Menghan Liu, Zhao Wang, Yini Wang   +5 more
doaj   +1 more source

Remission after Six Months of Induction Immunosuppressive Treatment with Mycofenolate Mofetil and Prednisolone in Patients with Lupus Nephritis: A Descriptive Cross-sectional Study

Journal of Nepal Medical Association, 2021
Introduction: Treatment of lupus nephritis consists of six months of induction immunosuppression followed by years of maintenance immunosuppression.
Shailendra Shrestha, Rahul Yadav
doaj   +1 more source

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study [PDF]

Intestinal Research, 2021
Background/Aims The efficacy and safety of vedolizumab in moderate to severely active ulcerative colitis (UC) have been demonstrated in the GEMINI 1 study (NCT00783718).
Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul   +7 more
doaj   +1 more source